logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Leading Pharmaceutical Innovation 3rd Ed Oliver Gassmann Alexander Schuhmacher

  • SKU: BELL-7147246
Leading Pharmaceutical Innovation 3rd Ed Oliver Gassmann Alexander Schuhmacher
$ 31.00 $ 45.00 (-31%)

4.3

28 reviews

Leading Pharmaceutical Innovation 3rd Ed Oliver Gassmann Alexander Schuhmacher instant download after payment.

Publisher: Springer International Publishing
File Extension: PDF
File size: 4.05 MB
Author: Oliver Gassmann, Alexander Schuhmacher, Max von Zedtwitz, Gerrit Reepmeyer
ISBN: 9783319668321, 9783319668338, 3319668323, 3319668331
Language: English
Year: 2018
Edition: 3rd ed.

Product desciption

Leading Pharmaceutical Innovation 3rd Ed Oliver Gassmann Alexander Schuhmacher by Oliver Gassmann, Alexander Schuhmacher, Max Von Zedtwitz, Gerrit Reepmeyer 9783319668321, 9783319668338, 3319668323, 3319668331 instant download after payment.

This book investigates and highlights the most critical challenges the pharmaceutical industry faces in an increasingly competitive environment of inflationary R&D investments and tightening cost control pressures. The authors present three sources of pharmaceutical innovation: new management methods in the drug development pipeline; new technologies as enablers for cutting-edge R&D; and new forms of cooperation and internationalization, such as open innovation in the early phases of R&D. New models and methods are illustrated with cases from Europe, the US, and Asia. This third fully revised edition was expanded to reflect the latest updates in open and collaborative innovation, the greater strategic importance of venture capital and early-stage investments, and the new range of emerging technologies now being put to use in pharmaceutical innovation.

Related Products